Sign up to The Irish Times Archive (1859 - 2008)My Account »
Sat 02 Feb 2010FDA posts safety notice on Tysabri
The US Food and Drug Administration (FDA) has placed a safety notice in relation to Elan’s multiple sclerosis drug Tysabri on its website.
The risk of a potentially fatal brain disorder with Tysabri increases as patients receive more infusions, the FDA says.
Choose a Subscription type - required
